Aligned Genetics, Inc. (KOSDAQ:238120)
3,245.00
-10.00 (-0.31%)
At close: Jun 16, 2025, 3:30 PM KST
Aligned Genetics Revenue
Aligned Genetics had revenue of 3.92B KRW in the quarter ending March 31, 2025, with 22.92% growth. This brings the company's revenue in the last twelve months to 16.51B, up 10.13% year-over-year. In the year 2024, Aligned Genetics had annual revenue of 15.78B with 3.70% growth.
Revenue (ttm)
16.51B
Revenue Growth
+10.13%
P/S Ratio
2.77
Revenue / Employee
246.40M
Employees
67
Market Cap
45.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.78B | 562.88M | 3.70% |
Dec 31, 2023 | 15.21B | 1.46B | 10.63% |
Dec 31, 2022 | 13.75B | 1.99B | 16.92% |
Dec 31, 2021 | 11.76B | 3.80B | 47.82% |
Dec 31, 2020 | 7.96B | 163.45M | 2.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
KB Financial Group | 14.93T |
Doosan Enerbility | 15.88T |